Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 43
TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102277BDBM102277(US9695165, 25)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102229BDBM102229(US9695165, 23)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103847BDBM103847(US9695165, 31 | US9695165, 30)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103847BDBM103847(US9695165, 31 | US9695165, 30)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103607BDBM103607(US9695165, 28)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103852BDBM103852(US9695165, 35)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103849BDBM103849(US9695165, 32)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103859BDBM103859(US9695165, 42)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103858BDBM103858(US9695165, 41)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103857BDBM103857(US9695165, 40)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103857BDBM103857(US9695165, 40)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103856BDBM103856(US9695165, 39)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103856BDBM103856(US9695165, 39)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103854BDBM103854(US9695165, 37)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103864BDBM103864(US9695165, 47)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103862BDBM103862(US9695165, 45)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103860BDBM103860(US9695165, 43)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102180BDBM102180(US9695165, 12)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103870BDBM103870(US9695165, 53)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102167BDBM102167(US9695165, 10)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103869BDBM103869(US9695165, 52)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102160BDBM102160(US9695165, 9)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103867BDBM103867(US9695165, 50)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102213BDBM102213(US9695165, 18)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102207BDBM102207(US9695165, 17)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102207BDBM102207(US9695165, 17)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103873BDBM103873(US9695165, 56)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102180BDBM102180(US9695165, 12)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102219BDBM102219(US9695165, 21)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102219BDBM102219(US9695165, 21)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102218BDBM102218(US9695165, 20)
Affinity DataIC50: 10nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102218BDBM102218(US9695165, 20)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102217BDBM102217(US9695165, 19)
Affinity DataIC50: 10nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103502BDBM103502(US9695165, 26)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102277BDBM102277(US9695165, 25)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102252BDBM102252(US9695165, 24)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102252BDBM102252(US9695165, 24)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102229BDBM102229(US9695165, 23)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 102226BDBM102226(US9695165, 22)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103847BDBM103847(US9695165, 31 | US9695165, 30)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103610BDBM103610(US9695165, 29)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103607BDBM103607(US9695165, 28)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103503BDBM103503(US9695165, 27)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103503BDBM103503(US9695165, 27)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103853BDBM103853(US9695165, 36)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103852BDBM103852(US9695165, 35)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103851BDBM103851(US9695165, 34)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103851BDBM103851(US9695165, 34)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetEukaryotic translation initiation factor 2-alpha kinase 3(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103849BDBM103849(US9695165, 32)
Affinity DataIC50: 55nMAssay Description:MDA-MB453 cells were plated in 96-well cell culture plates at a density of 1x105 cells. Cells were allowed to attach, and growth media was replaced w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Blueprint Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 103855BDBM103855(US9695165, 38)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:In each well of a 384-well plate, 0.5 ng/ul of wild type FGFR-4 (Carna Biosciences, Inc.) was incubated in a total of 12.5 ul of buffer (100 mM HEPES...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/26/2018
Entry Details
US Patent

Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: